Strategic partnerships Circular Genomics is actively forming collaborations with organizations across Alzheimer's and multiple sclerosis initiatives, including partnerships with Global Alzheimer's Platform Foundation and Decode Health. This indicates ripe opportunities for co-development, data sharing, and joint pilots that can expand your access to their precision circRNA platform.

CircPATH platform The launch of CircPATH following a Nature Medicine study signals a new product that targets early detection and risk stratification in neurology. This creates sales potential for platform licensing, implementation support, and integration with existing clinical workflows and diagnostics teams.

Strategic advisory Appointment of high-profile scientists like Henrik Zetterberg to the Scientific Advisory Board reinforces credibility and accelerates engagement with research partners and healthcare providers, offering engagement angles for seminars, sponsored studies, and advisory-driven pilot programs.

Multimodal collaborations Alliances with Vitazi.ai and Decode Health to develop multimodal workflows for early Alzheimer's detection and MS monitoring indicate a push toward integrated solutions. This presents opportunities to propose end-to-end technology stacks, data integration services, and joint go-to-market strategies.

Funding momentum Recent Series A agreement and a $15M investment demonstrate financial runway and validation of the strategy, enabling upsell of larger-scale deployments, expanded product tiers, and enterprise-grade support packages to healthcare systems and research networks.